Serum Sodium Alterations in Children with Primary Monosymptomatic Nocturnal Enuresis Using Desmopressin
Open Access
- 27 June 2022
- journal article
- research article
- Published by Brieflands in Nephro-Urology Monthly
- Vol. 14 (3)
Abstract
Background: Hyponatremia/water intoxication has been considered a rare but serious complication of desmopressin (DDAVP) for the treatment of primary monosymptomatic nocturnal enuresis (PMNE). Objectives: This study aimed to identify the incidence and risk factors of serum sodium (Na) alterations in children with PMNE treated with oral or intranasal DDAVP. Methods: A total of 201 patients with PMNE were evaluated in 2 groups using intranasal (n = 127) or oral DDAVP (n = 74) for approximately 6 months. Treatment efficacy was defined as a more than 50% decrease in wet nights after 1 month of treatment. Serum Na was measured before, during, and after treatment in all patients. Predisposing factors of serum Na disturbance were evaluated concomitantly. Results: The mean age of patients was 8.8 ± 2.6 (5 - 17.5) years, and males outnumbered females (M/F = 1.68). Treatment efficacy was 100% in 93 (46.2%), and > 90% in 157 (78.1%) cases. Oral DDAVP had significantly more therapeutic effects than intranasal treatment (P = 0.024). However, serum Na had no significant difference between the 2 groups (P = 0.52). Hyponatremia occurred in 7 (3.5%) patients (3 in oral treatment and 4 in intranasal treatment; P = 0.73) with no significant correlation to age, gender, body weight, frequency of enuresis, and initial serum Na. However, decreased serum Na > 5 mEq/L was a significant risk factor for the prediction of hyponatremia in our patients (P < 0.001). Conclusions: Oral DDAVP had more therapeutic effects than intranasal treatment for the treatment of PMNE. Serum Na had no significant alteration in both oral and intranasal treatments, and hyponatremia was a rare complication of DDAVP, which occurred significantly in children with a > 5-mEq/L decrease of initial serum Na concentration. As a suggestion, monitoring serum Na is not an essential follow-up in asymptomatic patients in DDAVP treatment.Keywords
This publication has 16 references indexed in Scilit:
- Severe signs of hyponatremia secondary to desmopressin treatment for enuresis: A systematic reviewJournal of Pediatric Urology, 2013
- Perioperative incidence and management of hyponatremia in vWD patients undergoing adenotonsillectomyThe Laryngoscope, 2011
- Desmopressin treatment regimens in monosymptomatic and nonmonosymptomatic enuresis: A review from a clinical perspectiveJournal of Pediatric Urology, 2011
- Desmopressin is an Effective Treatment for Mixed Nocturia with Nocturnal Polyuria and Decreased Nocturnal Bladder CapacityJournal of Korean Medical Science, 2010
- The Comparative Safety of Oral Versus Intranasal Desmopressin for the Treatment of Children With Nocturnal EnuresisJournal of Urology, 2007
- Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremiaNeurourology and Urodynamics, 2005
- DESMOPRESSIN ASSOCIATED SYMPTOMATIC HYPONATREMIC HYPERVOLEMIA IN CHILDREN. ARE THERE PREDICTIVE FACTORS?Journal of Urology, 2005
- THE EFFICACY AND SAFETY OF ORAL DESMOPRESSIN IN CHILDREN WITH PRIMARY NOCTURNAL ENURESISJournal of Urology, 2001
- Hyponatremic Seizure in a Child Using Desmopressin for Nocturnal EnuresisArchives of Pediatrics & Adolescent Medicine, 1998
- Hyponatremia and seizures in young children given ddavpAmerican Journal of Hematology, 1989